🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and assertions of rapid British shipping. Sellers promote the drug there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Worries

However, physicians and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users administering products of uncertain source.

Some professionals said the popularity for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Service Response and Content Removal

Based on TikTok, the platform has removed problematic content and banned related hashtags and query recommendations. The company stated it was committed to keeping the platform secure and investing in enhancing compliance measures.

Digital Marketplace Activities

Investigations also discovered communities with up to nine thousand members selling the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of weight loss, glowing testimonials and detailed guides for mixing or administering at residence.

After moments of joining one group, a seller shared contact information, where the majority of purchases take place. The seller sent an guidebook and promised delivery within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.

Product Information and Pricing

Inside these groups, messages show dark colored packages with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service stated it actively moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they can’t verify. Even if the science behind this drug is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her staff has already seen patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose patients to possibly serious health risks”.